The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
Croce S, Lesluyes T, Valle C, M'Hamdi L, Thébault N, Pérot G, Stoeckle E, Noël JC, Fontanges Q, Devouassoux-Shisheboran M, Querleu D, Guyon F, Floquet A, Chakiba C, Mayeur L, Rebier F, MacGrogan GM, Soubeyran I, Le Guellec S, Chibon F.
Croce S, et al. Among authors: fontanges q.
Clin Cancer Res. 2020 Feb 15;26(4):855-861. doi: 10.1158/1078-0432.CCR-19-2891. Epub 2019 Dec 3.
Clin Cancer Res. 2020.
PMID: 31796515